{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:56:16Z","timestamp":1768262176783,"version":"3.49.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001673","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01149","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T04:21:06Z","timestamp":1527135666000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance Concept"],"prefix":"10.3389","volume":"9","author":[{"given":"Daniel","family":"Satg\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/bmj.1.5022.779","article-title":"Cancer. A biological approach. The processes of control","volume":"6","author":"Burnet","year":"1957","journal-title":"Br Med J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"viii6","DOI":"10.1093\/annonc\/mds256","article-title":"Immuno-oncology: understanding the function and dysfunction of the immune system in cancer","volume":"23","author":"Finn","year":"2012","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry","volume":"141","author":"Mayor","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","article-title":"Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study","volume":"130","author":"Mellemkjaer","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1182\/blood-2010-03-272351","article-title":"Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?","volume":"116","author":"Vajdic","year":"2010","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clim.2014.10.003","article-title":"Primary immunodeficiencies in the Netherlands: national patient data demonstrate the increased risk of malignancy","volume":"156","author":"Jonkman-Berk","year":"2015","journal-title":"Clin Immunol"},{"key":"B8","first-page":"1263","article-title":"Development of cancer in patients with primary immunodeficiencies","volume":"28","author":"Salavoura","year":"2008","journal-title":"Anticancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1329.e","DOI":"10.1016\/j.jaci.2011.02.047","article-title":"Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies","volume":"127","author":"Rezaei","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ejmg.2016.03.001","article-title":"Genetic predisposition and hematopoietic malignancies in children: primary immunodeficiency","volume":"59","author":"van der Werff Ten Bosch","year":"2016","journal-title":"Eur J Med Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fimmu.2016.00365","article-title":"Cancers related to immunodeficiencies: update and perspectives","volume":"7","author":"Mortaz","year":"2016","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.clim.2009.01.010","article-title":"Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients","volume":"131","author":"Quiding-J\u00e4rbrink","year":"2009","journal-title":"Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/cup.12230","article-title":"Primary cutaneous marginal zone lymphoma with sequential development of nodal marginal zone lymphoma in a patient with selective immunoglobulin A deficiency","volume":"40","author":"Wobser","year":"2013","journal-title":"J Cutan Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s10875-013-9948-4","article-title":"IgA deficiency and mortality: a population-based cohort study","volume":"33","author":"Ludvigsson","year":"2013","journal-title":"J Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s10875-014-0124-2","article-title":"IgA deficiency and risk of cancer: a population-based matched cohort study","volume":"35","author":"Ludvigsson","year":"2015","journal-title":"J Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Italian primary immunodeficiency network. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.leukres.2015.02.002","article-title":"Lymphoproliferative disease and cancer among patients with common variable immunodeficiency","volume":"39","author":"Gangemi","year":"2015","journal-title":"Leuk Res"},{"key":"B18","first-page":"299","article-title":"X-linked ammaglobulinemia and autosomal recessive ammaglobulinemia","volume-title":"Primary Immunodeficiency Diseases. A Molecular and Genetic Approach","author":"Smith","year":"2014"},{"key":"B19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s10875-013-9971-5","article-title":"Gastric adenocarcinoma in the context of X-linked agammaglobulinemia: case report and review of the literature","volume":"34","author":"Staines Boone","year":"2014","journal-title":"J Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10875-015-0132-x","article-title":"Are patients with X-linked agammaglobulinemia at increased risk of developing acute lymphoblastic leukemia?","volume":"35","author":"Conley","year":"2015","journal-title":"J Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10875-017-0374-x","article-title":"Gastrointestinal manifestations in X-linked agammaglobulinemia","volume":"37","author":"Barmettler","year":"2017","journal-title":"J Clin Immunol"},{"key":"B22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.158.2.977","article-title":"Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM","volume":"158","author":"Hayward","year":"1997","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jaci.2015.02.020","article-title":"Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan","volume":"136","author":"Mitsui-Sekinaka","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jaci.2016.07.039","article-title":"Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation","volume":"139","author":"De la Morena","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","article-title":"A multiinstitutional survey of the Wiskott-Aldrich syndrome","volume":"125","author":"Sullivan","year":"1994","journal-title":"J Pediatr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0165-5876(03)00155-1","article-title":"Malignant B cell non-Hodgkin\u2019s lymphoma of the larynx in children with Wiskott Aldrich syndrome","volume":"67","author":"Palenzuela","year":"2003","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1182\/blood-2003-05-1480","article-title":"Clinical course of patients with WASP gene mutations","volume":"103","author":"Imai","year":"2004","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/pbc.23393","article-title":"Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome","volume":"59","author":"Coccia","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0022-3476(99)70456-7","article-title":"Increased incidence of cancer in patients with cartilage-hair hypoplasia","volume":"134","author":"M\u00e4kitie","year":"1999","journal-title":"J Pediatr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.jaad.2005.03.055","article-title":"Cartilage hair hypoplasia and multiple basal cell carcinomas","volume":"54","author":"Eisner","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1002\/ajmg.a.32478","article-title":"Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma","author":"Taskinen","year":"2008","journal-title":"Am J Med Genet A"},{"key":"B33","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s10875-013-9981-3","article-title":"Cartilage-hair hypoplasia: follow-up of immunodeficiency in two patients","volume":"34","author":"Kainulainen","year":"2014","journal-title":"J Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00277-002-0489-9","article-title":"Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome. Warts, hypogammaglobulinemia, infections, and myelokathexis","volume":"81","author":"Imashuku","year":"2002","journal-title":"Ann Hematol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tripleo.2009.08.011","article-title":"WHIM syndrome and oral squamous cell carcinoma","volume":"109","author":"Cipriani","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"B36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-7-71","article-title":"Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry","volume":"7","author":"Beaussant Cohen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/jdv.12927","article-title":"Primary cutaneous follicle center lymphoma in a patient with WHIM syndrome","volume":"30","author":"Yoshii","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1182\/blood-2012-01-406116","article-title":"Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia","volume":"119","author":"Beekman","year":"2012","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2141.2012.09171.x","article-title":"Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome\/leukaemia","volume":"158","author":"Carlsson","year":"2012","journal-title":"Br J Haematol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1182\/blood-2013-11-538025","article-title":"Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis","volume":"123","author":"Skokowa","year":"2014","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0091-6749(90)90155-W","article-title":"A patient with simultaneous absence of \"classical\" natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset","volume":"85","author":"Ballas","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1182\/blood-2011-10-385377","article-title":"Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency","volume":"119","author":"Shaw","year":"2012","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jaci.2013.07.020","article-title":"Natural killer cell deficiency","volume":"132","author":"Orange","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-3476(95)70491-4","article-title":"Cancer in children with primary or secondary immunodeficiencies","volume":"126","author":"Mueller","year":"1995","journal-title":"J Pediatr"},{"key":"B46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2017.06.009","article-title":"Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders","volume":"141","author":"Hauck","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","article-title":"Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation","volume":"107","author":"Suarez","year":"2006","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MOH.0b013e328302c7b6","article-title":"Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics","volume":"15","author":"Chua","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.leukres.2017.03.003","article-title":"Is there immune surveillance against chronic myeloid leukaemia? Possibly, but not much","volume":"57","author":"Gale","year":"2017","journal-title":"Leuk Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.cmi.2015.07.009","article-title":"Immunodeficiency-associated viral oncogenesis","volume":"21","author":"Pierangeli","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"B51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3389\/fimmu.2016.00545","article-title":"Genetic causes of human NK cell deficiency and their effect on NK cell subsets","volume":"7","author":"Mace","year":"2016","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.seminhematol.2017.05.002","article-title":"GATA2 deficiency and related myeloid neoplasms","volume":"54","author":"Wlodarski","year":"2017","journal-title":"Semin Hematol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1126\/science.183.4124.534","article-title":"Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice","volume":"183","author":"Stutman","year":"1974","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"5586","DOI":"10.4049\/jimmunol.175.9.5586","article-title":"Cutting edge: TRAIL deficiency accelerates hematological malignancies","volume":"175","author":"Zerafa","year":"2005","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1182\/blood-2005-05-2034","article-title":"Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy","volume":"106","author":"Airoldi","year":"2005","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/mi.2017.9","article-title":"Interleukin-22 drives nitric oxide-dependent DNA damage and dysplasia in a murine model of colitis-associated cancer","volume":"10","author":"Wang","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"50570","DOI":"10.18632\/oncotarget.10843","article-title":"Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction","volume":"8","author":"Jeon","year":"2016","journal-title":"Oncotarget"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.20021258","article-title":"Deficiencies of GM-CSF and interferon gamma link inflammation and cancer","volume":"197","author":"Enzler","year":"2003","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.clim.2010.01.008","article-title":"Nijmegen breakage syndrome: long-term monitoring of viral and immunological biomarkers in peripheral blood before development of malignancy","volume":"135","author":"Gregorek","year":"2010","journal-title":"Clin Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000356035","article-title":"A prime time for trained immunity: innate immune memory in newborns and infants","volume":"105","author":"Levy","year":"2014","journal-title":"Neonatology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pedneo.2015.08.007","article-title":"Solid cancers in the premature and the newborn: report of three national referral centers","volume":"57","author":"Raciborska","year":"2016","journal-title":"Pediatr Neonatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/08880010490273000","article-title":"Spontaneous remission in congenital leukemia is not related to (mosaic) trisomy 21: case presentation and literature review","volume":"21","author":"van den Berg","year":"2004","journal-title":"Pediatr Hematol Oncol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00247-007-0424-2","article-title":"Spontaneous remission of a diffuse brainstem lesion in a neonate","volume":"37","author":"Schomerus","year":"2007","journal-title":"Pediatr Radiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1046\/j.1440-1827.2002.01394.x","article-title":"Regression of congenital fibrosarcoma to hemangiomatous remnant with histological and genetic findings","volume":"52","author":"Miura","year":"2002","journal-title":"Pathol Int"},{"key":"B66","first-page":"296","article-title":"Spontaneous regression and cytodifferentiation of cancer in early life: the oncogenic grace period","volume":"4","author":"Bolande","year":"1985","journal-title":"Surv Synth Pathol Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2249.2009.03890.x","article-title":"Intrinsic defect of the immune system in children with Down syndrome: a review","volume":"156","author":"Kusters","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.0.CO;2-M","article-title":"A tumor profile in Down syndrome","volume":"78","author":"Satg\u00e9","year":"1998","journal-title":"Am J Med Genet"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2016.23","article-title":"Low risk of solid tumors in persons with Down syndrome","volume":"18","author":"Hasle","year":"2016","journal-title":"Genet Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature10803","article-title":"Expression of tumour-specific antigens underlies cancer immunoediting","volume":"482","author":"DuPage","year":"2012","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/ijc.20914","article-title":"Tumor-induced antibodies resemble the response to tissue damage","volume":"115","author":"Preiss","year":"2005","journal-title":"Int J Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","article-title":"Tumors as organs: complex tissues that interface with the entire organism","volume":"18","author":"Egeblad","year":"2010","journal-title":"Dev Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","article-title":"CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages","volume":"16","author":"DeNardo","year":"2009","journal-title":"Cancer Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","article-title":"The two faces of interferon-gamma in cancer","volume":"17","author":"Zaidi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"de Visser","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B76","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s12038-015-9543-3","article-title":"Cancer research in need of a scientific revolution: using \"paradigm shift\" as a method of investigation","volume":"40","author":"Wion","year":"2015","journal-title":"J Biosci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1073\/pnas.72.9.3585","article-title":"Normal genetically mosaic mice produced from malignant teratocarcinoma cells","volume":"9","author":"Mintz","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.2174\/1381612823666170609082757","article-title":"Tumor reversion: mesenchymal-epithelial transition as a critical step in managing the tumor-microenvironment cross-talk","volume":"23","author":"Bizzarri","year":"2017","journal-title":"Curr Pharm Des"},{"key":"B79","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/d41586-017-07267-9","article-title":"How T cells spot tumour cells","volume":"551","author":"Sarkizova","year":"2017","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01149\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:54:15Z","timestamp":1693684455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01149\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":79,"alternative-id":["10.3389\/fimmu.2018.01149"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01149","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"article-number":"1149"}}